Cincinnati Children’s launches a pivotal clinical trial for KiteLock therapy—a breakthrough approach to reducing catheter complications in pediatric intestinal failure patients.
Cincinnati Children’s and Akron Children’s mark one year of collaboration to expand access to expert pediatric liver care across Northeast Ohio.
Discover how Cincinnati Children’s is improving eosinophilic gastrointestinal disorder (EGID) care with FDA-approved drugs, transnasal endoscopy, and advanced diagnostic scoring systems.
Cincinnati Children’s researchers use AI and imaging to predict IBD outcomes, aiming to improve diagnosis, therapy selection, and patient care.
Discover how Cincinnati Children’s DGBI program is transforming care for complex GI disorders through multidisciplinary treatment and cutting-edge research.
Cincinnati Children’s unveils a dedicated GI suite with advanced imaging, improving precision, safety, and efficiency in pediatric procedures.
FDA-approved therapies now make hepatitis C curable in children—but greater awareness and screening are needed to close critical gaps in care.
Cincinnati Children’s expands transnasal endoscopy access—offering unsedated, outpatient evaluations for eosinophilic disorders with proven diagnostic value.